59.6 F
New York
Monday, November 30, 2020

Novavax Inc. (NASDAQ:NVAX) Recent Earnings Shows Major Concern

Must read

Is the Rough Ride Over for AnPac Bio-Medical Science Co. Ltd. (ANPC)

AnPac Bio-Medical Science Co. Ltd. (ANPC) shares are trading at lower $6.20 and the avg recommendation for the stock is Moderate Buy. To add...

Renewed Optimism is Surrounding Graphic Packaging Holding Company (NYSE:GPK)

Graphic Packaging Holding Company (GPK) shares are trading at higher $15.56 and the avg recommendation for the stock is Moderate Buy, while the current...

The Last Few Sessions Have NexTier Oilfield Solutions Inc. (NEX) Soaring

NexTier Oilfield Solutions Inc. (NEX) shares are trading at lower $3.02 and the avg recommendation for the stock is Moderate Buy, while the current...

Will The Blackstone Group Inc. (BX) Find a Support Level Soon?

The Blackstone Group Inc. (BX) shares are trading at higher $60.53 and the avg recommendation for the stock is Moderate Buy, while the current...

Novavax Inc. (NVAX) shares are trading at lower $143.13 and the avg recommendation for the stock is Moderate Buy. while the current analyst price target stands at $227.60.

To add more color to this target, the company’s high over the last year is $189.40 and the low is $3.54. Over the last 52 weeks, NVAX is down -24.43% while the S&P 500 is up 0.31%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, NVAX reported a profit of $52.56 million. Novavax Inc. also saw revenues increase to $35.54 million. In addition, NVAX has free cash flow of $88.64 million as of 06-2020. The company’s EBITDA came in at -$15.69 million which compares well with its peers.

NVAX Return on Equity (ROE) is 173.30%, and its Return on Assets is -23.30%. All told, it is clear that, NVAX needs to be on your watchlist.

Find out when NVAX reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. NVAX has a short ratio of 0.97 and outstanding shares of 58.62M.

Company Outlook

NVAX has seen increased volume after this news and investors are putting their support behind the value proposition. Traders will also note the company’s earnings per share came in at -2.76. Novavax Inc. NVAX also noted assets of $932.23 million at the end of the last quarter. Investors should also keep an eye on sector updates as NVAX has historically followed its peers on positive news.

All told, Novavax Inc. NVAX has strung together solid data and demonstrated underlying fundamentals. At its current valuation, NVAX represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Novavax Inc. NVAX is now commanding a market cap of 7.98B and a float of 57.49M. NVAX is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of NVAX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in NVAX, either long or short, and we have not been compensated for this article.

Latest article

NextEra Energy Inc. (NYSE:NEE) is Waving the Bear Flag

NextEra Energy Inc. (NEE) shares are trading at lower $75.13 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

The Forecast Just Changed on CIIG Merger Corp. (NASDAQ:CIIC)

CIIG Merger Corp. (CIIC) shares are trading at lower $24.10. To add more color to this target, the company’s high over the last year...

Kingsoft Cloud Holdings Limited (NASDAQ:KC) on the Path to Profitability

Kingsoft Cloud Holdings Limited (KC) shares are trading at higher $41.56 and the avg recommendation for the stock is Strong Buy, while the current...

The Last Few Sessions Have The Unilever Group (UL) Soaring

The Unilever Group (UL) shares are trading at lower $60.51 and the avg recommendation for the stock is Strong Buy, while the current analyst...

Arbutus Biopharma Corporation (NASDAQ:ABUS) Stock is Soaring, Here is Why

Arbutus Biopharma Corporation (ABUS) shares are trading at higher $4.34 and the avg recommendation for the stock is Moderate Buy, while the current analyst...